Meanwhile, the clinical relevance of serum ApoJ to lipid parameters was examined in both chronic hepatitis C (CHC) and NAFLD patient groups, and in mice fed with HFD. This evidence concerns the gene CLU and metabolic dysfunction-associated steatotic liver disease.